Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial

By Proactive Investors / December 06, 2023 / www.youtube.com / Article Link

Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia ...

Recent News

Gold not the consensus play anymore

July 20, 2026 / www.canadianminingreport.com

Gold stocks drop to lowest levels this year

July 20, 2026 / www.canadianminingreport.com

A rebalancing of gold's ratios versus major commodities

July 14, 2026 / www.canadianminingreport.com

Gold stocks down on slide in gold price

July 14, 2026 / www.canadianminingreport.com

US tariff decision expected to be major copper catalyst

July 07, 2026 / www.canadianminingreport.com

See all >